Construction and Expression of Recombined Human AFP Eukaryotic Expression Vector

LW Zhang,J Ren,L Zhang,HM Zhang,B Jin,BR Pan,XM Si,YJ Zhang,ZH Wang,YL Pan,SM Festein
DOI: https://doi.org/10.3748/wjg.v9.i7.1465
IF: 5.374
2003-01-01
World Journal of Gastroenterology
Abstract:AIM:To construct a recombined human AFP eukaryotic expression vector for the purpose of gene therapy and target therapy of hepatocellular carcinoma (HCC).METHODS:The full length AFP-cDNA of prokaryotic vector was digested, and subcloned to the multi-clony sites of the eukaryotic vector. The constructed vector was confirmed by enzymes digestion and electrophoresis, and the product expressed was detected by electrochemiluminescence and immunofluorescence methods.RESULTS:The full length AFP-cDNA successfully cloned to the eukaryotic vector through electrophoresis, 0.9723 IU/ml AFP antigen was detected in the supernatant of AFP-CHO by electrochemiluminescence method. Compared with the control groups, the differences were significant (P<0.05). AFP antigen molecule was observed in the plasma of AFP-CHO by immunofluorescence staining.CONCLUSION:The recombined human AFP eukaryotic expression vector can express in CHO cell line. It provides experimental data for gene therapy and target therapy of hepatocellular carcinoma.
What problem does this paper attempt to address?